News related to
Power

HONG KONG SAR – Media OutReach Newswire – 13 August 2026 – Bora Pharmaceuticals (“Bora”; TWSE: 6472; OTCQX: BORAY) today announced its financial results and operational highlights for 2Q2026 and provides full year outlook update.

2Q26 Business and Financial Highlights

  • Bora delivered historically record-high quarterly revenues of NT$5,889 million in 2Q26, up 47.2% quarter-over-quarter driven by broad-based operational momentum, with basic EPS of NT$4.36.
  • CDMO revenue growth and increased site utilization rates, along with strong growth in the rare disease business and a return to growth for generics business of the Pharma Sales operations lifted group profitability, with gross margin expanding to 41.3% from 36.0% and operating margin reaching 16.8% from 10.2% in 1Q26. Excluding one-time costs related to the Weider Global Nutrition transaction, operating margin was approximately 18%.
  • CDMO’s strong backlog of US$317 million as of end of 2Q26, another historical high following a strong quarter, signals that Bora’s core business continued to perform with higher demand.
  • Pharma Sales’ rare disease franchise continues to show double digit sequential growth and the increased demand from government channels during the quarter with stabilized pricing in DLS has lifted the generics business back to normal.
  • Reflecting Bora’s recent increase in investment in Sunway Biotech, from 35.97% to 42.27% and subsequent acquisitions of Weider Global Nutrition’s, the Company has introduced “Consumer Healthcare (CHC)” as a new segment in its revenue mix disclosure beginning this quarter. In 2Q26, revenues from CHC were NT$824.76 million in 2Q26, a 354.4% increase QoQ and 234.3% YoY, and contributed to 14% of the Bora Groups consolidated revenues, an all-time high.
  • Cash-on-hand reached an all-time high of NT$8,431 million as the Company was preparing for MacroGenics Inc.’s Rockville facility acquisition.
  • The Company has kicked off a group-wide AI in Manufacturing, BORA AIM, program aimed at improving process efficiency across sites, spanning engineering, quality and production. Bora has also signed a partnership with Insilico Medicine for AI drug discovery. The first 6 months will focus on beta version testing of the Bora AIM agents and AI champions to drive process consolidation.
  • Share capital increased 0.3% during the quarter from employee stock option exercise.


Mr. Bobby Sheng, Chairman of Bora Group, stated, “We are pleased to announce Bora Group’s return to strong operating profits and double to triple-digit growth on all key margins sequentially, as well as demonstrate that our soft 1Q26 performance was anomalous rather than structural. Our impressive sequential improvement was driven entirely by strong demand from both our CDMO and Pharma Sales businesses, with 2Q26 manufactured batches reaching 0.38 billion doses, led by increased commercial production in Maple Grove and Zhunan sites and a full quarter of operations in the Maryland injectable facility, while our flagship products DLS and VIGAFYDE® in Pharma Sales continues to secure leading market share.

Our focus right now is execution. CAPEX investments in our mature sites, including facilities in Taiwan and in Canada, continue to deliver operational leverage driven by gross margin expansion, and our recently acquired oral solid dose facility in Maple Grove continues to show stellar and impactful demand as we sign more projects. Our 12-month rolling backlog is at historic high in almost all our sites, despite projected manufacturing delays at our Maryland injectable facility as we diligently respond to FDA audit observations from a recent audit. Bora Group’s commitment to the fast-growing Biologics manufacturing industry took another big step as we look to integrate 12,000 liters of capacity, and 3 commercial products from our Rockville facility, as well as see revenue recognition from this acquisition starting Q3. As Bora’s CDMO footprint expands in the US, we continue to capture durable, high-value demand as customers increasingly prioritize supply security and onshore capacity.

In addition, we are seeing sustained growth and improved gross margins in the Vigabatrin franchise, our most important, rare disease franchise, thanks to renegotiations with our partner vendors. Accelerated state and government orders for generics products increased 2Q26 revenues and 6 new generics launches have also supported a more diversified generics portfolio. Together, the advancement in rare disease franchise and generics business has positioned Bora’s Pharma Sales business, operating under the name Upsher-Smith, in a far stronger state than it was just a quarter ago.

As announced in July, we are excited to be developing a group-wide AI in Manufacturing program, BORA AIM, aimed at improving process efficiency across sites, spanning engineering, quality and production. We also announced a partnership with Insilico Medicine to enhance our understanding of AI drug discovery and create more customized AI manufacturing platforms for AIDD small molecules. In the next 12 months, Bora Group will be ready to showcase some exciting AI-enabled CDMO platforms that will truly add value to our partners and sharpen the overall competitive advantages of Bora Group.

As our momentum carries Bora into the second half of the year, we expect margins of our flagship products in Pharma Sales and CHC businesses to hold steady on continuous revenue growth, and improved efficiencies in the CDMO business in addition to consolidation of new revenues from the Rockville facility.”

2Q26 Operational Achievements & 2026 Outlook


Global CDMO Operations

Revenues increased 30.3% year-over-year and 29.0% quarter-over-quarter including internal orders, and 33.0% and 40.2% external orders only, or NT$2,116.4 million. The growth was primarily driven by a strong rebound in injectables following the semi-annual maintenance in 1Q26 and same period last year, and demand acceleration overall as we continue to meet the increasing backlog.

CDMO business also signed a record high US$378.2 million in total external wins. Highlighted by a 10+2-year, multi product commercial contract in our Maple Grove facility with a new top-20 pharma company, and 14 new molecules from pre-commercial programs from multiple new customers. Bora is confident in its mid- to long-term growth trajectory as pharma and biotech companies continue to look for US based CDMOs as a part of their efforts to onshore US production and improve supply chain resilience.

During the quarter, 0.38 billion doses, or 109 molecules, were developed and manufactured. Contribution from the top 20 global pharmaceutical companies stood at roughly 30% and should increase drastically in the next 8 quarters.

Looking at 3Q26, the Company is highly optimistic, with our backlog having climbed to an unprecedented level even after a strong quarter of manufacturing output. We do anticipate some timing shifts in revenue recognition related to scheduled semi-annual maintenance at our Maryland injectable site, alongside targeted quality-enhancement activities in connection with observations on passive RABS (Restricted Access Barrier System) line received from an FDA audit that took place 2Q26. However, there has been no reduction in total commercial batch productions in 2026 as we speak and several existing clients have initiated transfers to the FlexPro isolator filling lines. RFP activity has risen, with the first GMP PPQ campaign starting in August. On the newest, isolator-based AST lines, factory acceptance testing (FAT) is planned for Q326, with qualification to follow in 2027, expanding our ability to onboard small-scale isolator programs, including tech transfers.

On biologics, Rockville facility revenue recognition started in the first month of 3Q26 and the site has confirmed that it is on track to deliver batch production volumes ahead of last year’s run rate of around 13 batches for the remainder of 2026. We anticipate one-time transaction costs from this acquisition of approximately 3% of the purchase price including legal and FA fee and transition related expenses as stated in the Transition Service Agreement. The Rockville acquisition expands biologics capacity and brings integrated drug substance (DS) and drug product (DP) capabilities under one roof, strengthening our end-to-end service offering and attracting more inbound opportunities and higher value conversion with cross selling opportunities for our injectable business.

For our strategic investment in Tanvex Biopharma, the main Bora Biologics platform company, although the business still operates at a loss, Tanvex has built a strong presence in international conferences, especially Bio International in the US in June. We have seen a positive uptick in pipeline from leading biotechs and heavy weight biopharmas, and stable demand for early-stage PD programs in Zhubei. The Rockville acquisition is expected to orchestrate and accelerate opportunities for Tanvex in the coming quarters.

Pharma Sales Operations

Revenues decreased 2.7% year-over-year and increased 30.4% quarter-over-quarter, arriving at NT$2,934.04 million in 2Q26. The year-over-year decrease was mainly due to a product rationalization program in 2025 that lead to the withdrawal of a basket of legacy generics products.

During the quarter, specialty and brand came in strongly, up 58.8% for the quarter QoQ and displayed almost 50% growth against 2025 run rate. The rare-disease Vigabatrin franchise demand is robust, and our continuous investment in the segment has resulted in much broader patient access compared to when we acquired Upsher-Smith 28 months ago. On coverage, we are on track to achieve year-end formulary goal of >50%, supported by more regional plans and strong physician adoption as they gain experience with VIGAFYDE®. The Company has also renegotiated contracts with suppliers, leading to improved gross margins for the franchise during the quarter and expects full economic contribution starting 3Q26. Simultaneously, the Company out-licensed its non-core assets, Stiripentol generics and 505(b)(2), during the quarter, fully capturing the economic value of these drug assets to enable fueled and renewed focus on core specialty and brand business.

The generics business returned to stability as Upsher-Smith successfully defended flagship product DLS. High value generics advanced 20.6% sequentially from downstream restocking, narrowing the year-to-date YoY decline against 2025 run rate to high teens.

Having executed our way through specialty and brand business growth and generics portfolio optimization, we have returned to the 2023–2024 peaks of Pharma Sales performance but with healthier and more resilient operating profits. As of now, Upsher-Smith sees 6 ANDA pending approval.

CHC Operations

Bora Group has increased holdings of Sunway Biotech to 42.27% through a private placement at $NT 596 million. Subsequently, Sunway completed the acquisition of Weider Global Nutrition (WGN), a global nutritional supplements company with offices in the US, Spain, and Germany and products sold in over 60 countries. Benefitting from the consolidation of WGN that started in May, Consumer Health business totaled NT$824.76 million in 2Q26, a 354.4% increase QoQ and 234.3% YoY. Focusing on longevity and sports nutrition, WGN’s distribution strength is expected to meaningfully contribute to the CHC business in 2026 and beyond and shall deliver vertical-integration synergies to Sunway’s existing ingredients’ manufacturing operations. Together, the WGN acquisition is expected to catapult Sunway Biotech into a leading global nutritional supplements company and substantially accelerate top and bottom-line improvements in the future.

Recent Investor Conference

Bora will host English online earnings call at 8:00 a.m. Taiwan time on Aug. 14th, 2026. The event will cover the Company’s 2Q26 financial and business results and 2H26 outlook.

English Online Earnings Presentation Link: https://teams.microsoft.com/meet/225504163505748?p=UyyncWl1CnOzjBCNKD

Bora will participate in Goldman Sachs 2026 CDMO day in Singapore in Sept. For 1:1 meetings with management, please contact your GS representative.

Bora 2026 Earnings Schedule

Q3 2026: Expected in the 2nd week of Nov 2026
Q4 2026: Expected in the 2nd week of Mar 2027

Hashtag: #BoraGroup

The issuer is solely responsible for the content of this announcement.

About Bora

Founded in 2007, Bora Pharmaceuticals (“Bora” or “the Company”, 6472.TW and BORAY.OTCQX) is a leading pharmaceutical services company with a vision and goal of “Contributing to Better Health All Over the World”. Operating under a “Dual Engine” model that integrates CDMO and commercial expertise, we empower pharmaceutical and biotech partners to optimize product development, accelerate launches, and scale supply to meet global patient needs. At the same time, we actively broaden R&D and sales infrastructure, focusing on niche and rare disease markets to improve patients’ quality of life.

By investing in talent, infrastructure, and biologics expansion, Bora continues to transform operations and achieve sustainable growth. Committed to making success “certain,” Bora sets new standards in the pharmaceutical and CDMO industries.

For more, please visit:

Disclaimer:

This document and the accompanying information may contain forward-looking statements. All statements regarding the company’s future business operations, potential events, and prospects (including but not limited to forecasts, targets, estimates, and operational plans) are considered forward-looking statements unless they refer to factual occurrences. Forward-looking statements are subject to various factors and uncertainties that may cause significant differences from actual results, including but not limited to price fluctuations, actual demand, exchange rate variations, market share, competitive conditions, changes in the legal, financial, and regulatory framework, international economic and financial market conditions, political risks, cost estimates, and other risks and variables beyond the company’s control. These forward-looking statements are based on current predictions and assessments, and the company disclaims any responsibility for future updates.

North Korean operatives are using stolen identities, artificial intelligence and networks of overseas facilitators to secure remote technology jobs at US companies, exposing weaknesses in corporate hiring systems while generating money for Pyongyang. A year-long investigation into the operation found that workers linked to North Korea have infiltrated American businesses by assuming the identities of US citizens, creating convincing professional profiles and using AI tools to help […]

Arabian Post Staff -Dubai Google has removed false information from its search results that declared OpenAI chief executive Sam Altman dead, after vandalism of public information sources fed incorrect data into one of the search engine’s prominent information panels. The error appeared on August 12, when searches for Altman displayed a death date of August 12, 2026. Screenshots of the result spread rapidly across X and Reddit […]

Meta has deactivated 756,000 Facebook and Instagram accounts suspected of belonging to Australians under the age of 16 as enforcement of the country’s landmark social media restrictions intensifies. The company said 462,000 Instagram accounts and 294,000 Facebook accounts were removed between the period immediately before the rules took effect in December 2025 and June 2026. The figures represent one of the clearest indications yet of the scale […]

Zerohash is preparing to submit a narrower application for a US national trust bank charter after regulators returned its first filing without reaching a decision, creating a regulatory setback for the digital-asset infrastructure provider that powers cryptocurrency trading for Morgan Stanley’s E*Trade platform. The Chicago-based company expects to refile with the Office of the Comptroller of the Currency by the end of August, restructuring its proposal around […]

The UAE’s new restrictions on social media access for children under 15 could reach far beyond conventional social networks, drawing gaming, streaming, education, ecommerce and other digital services into a widening child-safety compliance regime. Cabinet Resolution No. 106 of 2026 sets 15 as the minimum age for maintaining a personal social media account. Children below that threshold cannot create, use or operate covered accounts or access features […]

Cloudflare recorded a sharp escalation in high-bandwidth distributed denial-of-service attacks during the second quarter of 2026, mitigating 805 network-layer attacks that exceeded 1 terabit per second as attackers increasingly deployed overwhelming bursts of traffic against online infrastructure. The figure was more than six times the 130 terabit-scale attacks recorded during the first quarter. It brought the total number of attacks exceeding 1 Tbps during the first half […]

Advertisements

Arabian Post Staff -Dubai Bangladesh Railway has received the first rake of 19 customised Linke Hofmann Busch broad-gauge passenger coaches manufactured at the Rail Coach Factory in Kapurthala, advancing a 200-coach procurement programme aimed at modernising its passenger fleet. The rake rolled out on August 12 with three air-conditioned sleeper coaches, three air-conditioned chair cars, 11 non-air-conditioned chair cars and two power cars. The coaches have been […]

Iran has reshaped its military leadership around battle-tested hardliners and ordered stronger offensive capabilities as negotiations with the United States remain deadlocked, signalling that Tehran is preparing for a prolonged confrontation rather than an early settlement to the Gulf war. Supreme Leader Ayatollah Mojtaba Khamenei has appointed six senior commanders across the Armed Forces General Staff, Islamic Revolutionary Guard Corps and Basij, placing veterans with extensive operational, […]

Google has unveiled its Pixel 11 smartphone range with higher starting prices, a new Tensor G6 processor and deeper Gemini integration, placing artificial intelligence at the centre of its latest challenge to Apple and Samsung. The Pixel 11 starts at $899, while the Pixel 11 Pro is priced from $1,099 and the larger Pixel 11 Pro XL from $1,299. All three models are available for pre-order and […]

President Donald Trump’s administration is preparing White House construction and modernisation projects costing at least $927 million, with much of the expenditure expected to be financed with public money transferred through federal accounts. The planned spending represents a substantial expansion of work across the presidential complex, encompassing the East Wing redevelopment, security infrastructure, a visitor screening centre, improvements around Lafayette Square and a new helipad. More than […]

Cognition AI has opened preliminary discussions with investors over a fresh capital raise that could value the fast-growing artificial intelligence coding company at at least $40 billion, marking another sharp escalation in investor expectations for autonomous software development tools. The talks remain at an early stage and the size, valuation and investor line-up could change before any transaction is completed. A $40 billion valuation would nevertheless represent […]

By K Raveendran Another session of Parliament has closed with an uncomfortable sense of déjà vu. Repeated adjournments, slogan-shouting, demonstrations inside and outside the chambers and legislation moving through amid uproar have again raised the question of whether Parliament is performing the function for which representative democracy created it. The problem is no longer simply […]

The article Parliament Is Losing The Argument To The Smartphone appeared first on Latest India news, analysis and reports on Newspack by India Press Agency).

BEIJING, CHINA – Media OutReach Newswire – 12 August 2026 – SOKOYO, a top manufacturer of solar street lights, has installed 252 sets of lighting units in QatarEnergy‘s solar power project in Ras Laffan and Masaieed in Qatar.

SOKOYO's installed in a municipal lighting project in an Asian country.
SOKOYO’s installed in a municipal lighting project in an Asian country.

Installation of SOKOYO‘s split solar street lights for the project being built by Samsung C&T Corp. was completed in July. The arrangement of solar panels was customized at the customer’s request for ease of maintenance.

“SOKOYO provided us with a specially customized solution for our power station,” said Ms. Kathy, senior procurement manager for Samsung. “The entire solar street lighting system consistently met our expectations for brightness, battery life and overall reliability.”

SOKOYO, founded in 2008, has manufactured more than 1 million lighting units installed in a wide range of settings across SoutheastAsia, Africa, the Middle East and Central Asia.

The company manufactures its own LED modules, solar panels, batteries, light housings and light poles. They have third-party certification for European Union and other safety and reliability standards, which qualifies them for export to global markets.

SOKOYO is regularly appointed to bodies that establish national and industry standards.

SOKOYO‘s product line includes all-in-one solar street lights, all-in-two solar street lights and split-type solar street lights. They can be controlled remotely with IoT technology to improve safety and efficiency. Using solar power makes them immune to disruptions in supplies of oil and gas.

As the industry evolves to focus on “system-level R&D,” SOKOYO is reducing customer costs by enhancing reliability and resistance to heat and cold. To improve efficiency, it is developing smart lighting and IoT applications. It is promoting modular production, intelligent manufacturing and standardized process management.

The research team has seven engineers, some with more than two decades of industry experience. They develop technology for a wide range of environments and customer needs.

SOKOYO has experience in markets including Thailand, thePhilippines, Pakistan, Saudi Arabia and Nigeria. It has developed technology to cope with heat, humidity, sandstorms and low light during extended rains, a challenge in central Africa and other areas.

In Uganda, SOKOYO supplied 1,000 light sets to help improve safety on a busy expressway between the capital, Kampala, and the eastern industrial center of Jinja. They provide the first nighttime lighting on a 22-kilometer section of road crowded with trucks, buses and motorcycles.

In Yemen and the United Arab Emirates, SOKOYO lights use LED modules developed to cope with heat, sun and sand.

The company supplied more than 2,000 light units to Saudi Arabia‘s planned high-tech city of NEOM as part of the Saudi 2030 Vision plan.

An aerial view of SOKOYO's industrial manufacturing park, supporting global B2B projects.
An aerial view of SOKOYO’s industrial manufacturing park, supporting global B2B projects.

Customers can use SOKOYO‘s test facilities to try out different light configurations. Lights can be tested on roads of up to four lanes in an1,100-square-meter darkroom. Designers and urban planners can ensure light is distributed effectively, eliminating dark areas on the road and improving safety.

Batteries are tested to confirm they resist crushing, heat and cold, vibration, overcharging or being dropped. LED modules are drenched in salt spray for up to 72 hours to make sure they resist corrosion.

SOKOYO has been chosen for bodies that formulated eight national and industry standards including the “General Technical Specification for Solar Photovoltaic Lighting Devices” in 2025 with definitions and standards for split-type and integrated solar devices.

SOKOYO products have third-party certification that they meet standards of the International Electrotechnical Commission (IEC) and other bodies.Its batteries meet the requirements of the CB scheme under the IEC, recognized in more than 50 countries. Tests confirm they withstand overcharging, high temperature, vibration, impact and short circuit.

The company‘s solar panels received IEC certification that they meet standards for electric shock protection, temperature changes, damp, heat, humidity, hail impact and other factors.

SOKOYO participates in efforts to improve the industry‘s reputation by promoting “zero false labeling” and reliable products that refuse to cut corners.

SOKOYO pays attention to the environment. Its products are designed to minimize light pollution and limit disruption for wildlife, stargazers and the public.

Hashtag: #SOKOYO

The issuer is solely responsible for the content of this announcement.

Rackspace Technology posted modest second-quarter revenue growth as stronger private cloud sales offset weakness in its larger public cloud business, while higher costs and investment in artificial intelligence pushed the company deeper into the red. The San Antonio-based cloud and technology services group generated revenue of $670.1 million for the three months ended June 30, up 0.6% from $666.3 million a year earlier. Private Cloud revenue climbed […]

KOTA DAMANSARA, MALAYSIA – Media OutReach Newswire – 12 August 2026 – Thomson Hospital Kota Damansara (“Thomson”) is the first hospital in Malaysia to introduce a next-generation integrated surgical energy platform into its operating theatres. This innovation strengthens its minimally invasive surgical capabilities and enhances patient experience.

From left: Dr Savitha Dharan, CEO of Thomson Hospital Kota Damansara, Dr Wong Sze Ming, Consultant General & Colorectal Surgeon, Jo-Ann Gan, Commercial Lead (Surgery) Malaysia & Brunei, J&J MedTech, Prof Dr Prasanna Supramaniam, Consultant in O&G, Fertility Specialist, Subspecialist in Reproductive Medicine, Minimal Invasive Gynaecological Surgeon & Ng Yee Voon, Senior General Manager, Thomson Fertility.
From left: Dr Savitha Dharan, CEO of Thomson Hospital Kota Damansara, Dr Wong Sze Ming, Consultant General & Colorectal Surgeon, Jo-Ann Gan, Commercial Lead (Surgery) Malaysia & Brunei, J&J MedTech, Prof Dr Prasanna Supramaniam, Consultant in O&G, Fertility Specialist, Subspecialist in Reproductive Medicine, Minimal Invasive Gynaecological Surgeon & Ng Yee Voon, Senior General Manager, Thomson Fertility.

Multidisciplinary Tertiary Hospital with Comprehensive Surgical Capabilities

As a multidisciplinary tertiary hospital, Thomson offers minimally invasive surgery across a broad range of specialties through laparoscopic, thoracoscopic (VATS), endoscopic, arthroscopic, and microsurgical approaches.

Thomson has also further expanded to its wide range of surgical offerings with two advanced procedures: the Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA), a scarless thyroid surgery performed through the mouth that eliminates visible neck incisions, and laparoscopic surgery for endometriosis, a keyhole procedure that enables the diagnosis and treatment of endometriosis through small incisions. Together, these procedures provide patients with more treatment options while supporting faster recovery where clinically appropriate.

Dr Savitha Dharan, Chief Executive Officer of Thomson Hospital Kota Damansara, explains, “Our aim is to provide patients with access to comprehensive, outcome driven surgical care under one roof. By continuously expanding our minimally invasive surgical capabilities, we empower our multidisciplinary teams to tailor the most appropriate treatment for every patient while delivering care that prioritises safety, precision and better patient outcomes.”

Advancing Surgical Care Through Technology

This next-generation integrated surgical energy platform brings multiple surgical energy technologies together on one platform, equipping surgeons with advanced technology that supports greater surgical precision and shorten overall procedure times. By combining tissue dissection and vessel sealing on a single platform, it enables more efficient surgical workflows targeted in reducing operating times, tissue trauma and recovery time where clinically appropriate.

“When investing in technology, Thomson’s main priority is delivering value-based care; we want better patient outcomes, operational efficiency and long-term value for both patients and our clinical team. This platform allows us to do just that – perform precise minimally invasive procedures and help deliver safe, effective care tailored to each patient’s clinical needs,” Dr Savitha expanded further.

Supported by experienced multidisciplinary teams and modern operating theatres, Thomson continues to invest in technologies that enhance surgical capabilities and improve the overall patient journey.

Supporting Sustainable Healthcare

Beyond its clinical benefits, this advanced integrated surgical energy platform aligns with Thomson’s Environmental, Social and Governance (ESG) commitments by reducing equipment redundancy and improving operating theatre efficiency. This enables the hospital to optimise resource utilisation while continuing to deliver high-quality patient care.

The introduction of the advanced integrated surgical energy platform marks another milestone in Thomson’s ongoing investment in advanced medical technologies, reinforcing its position as one of Malaysia’s leading private hospitals committed to innovation, clinical excellence and patient-centred care.

KKLIU 3218 / EXP 31.12.2028

Hashtag: #ThomsonHospital

The issuer is solely responsible for the content of this announcement.

About Thomson Hospital Kota Damansara

Thomson Hospital Kota Damansara (“Thomson”), the flagship hospital of TMC Life Sciences Berhad, is a multi-disciplinary tertiary care centre strategically located in the prime alcove of Kota Damansara, Selangor, established in 2008. Thomson holds a capacity for 554-beds including 25 critical care beds, and houses more than 160 consultant specialists across over 60 specialties and sub-specialties.

An award-winning institution, Thomson’s regional accolades include recognition by and as one of Asia’s Top Private Hospitals and Clinics 2026, awarded the Specialist Hospital of the Year, and Specialty Hospital of the Year – Malaysia in 2024 for paediatric services and in 2025 for pulmonology services.

Guided by its vision to be the “Premier Provider of Outstanding Value-Based Medical Services in Southeast Asia”, Thomson remains committed to clinical excellence and is poised for continued growth to meet evolving healthcare needs.

For more information, please visit or follow THKD on social media platforms @thomsonhospitalKD.

Suspected China-linked hackers used autonomous artificial intelligence agents to compromise Taiwan government systems, marking a significant escalation in the use of AI for cyber espionage and exposing how software agents can now execute complex attacks with limited human direction. The campaign unfolded over four days at the beginning of July and targeted 21 government systems. The attackers deployed as many as eight AI agents simultaneously to map […]

HandyGames has rebranded its publishing business as THQ Nordic Mobile, sharpening its focus on adapting premium PC and console games for smartphones and tablets while keeping its long-established development operation under the HandyGames Studios name. The change, effective from August 2026, brings the German publisher more visibly under the THQ Nordic brand eight years after the companies joined forces. THQ Nordic Mobile will operate as a dedicated […]

SINGAPORE – Media OutReach Newswire – 12 August 2026 – Artificial intelligence is driving one of the largest infrastructure investment cycles in decades, but the rapid global build-out of data centers is also creating a new era of construction, operational, climate and insurance risks, according to the latest Allianz Commercial The data center construction boom: risks and claims trends report. Annual investment in data centers is projected to double from around US$500bn in 2024 to more than US$1trn as early as 2027. The investment opportunity extends far beyond server halls to electricity generation, grid infrastructure, cooling, networking, and semiconductors. According to Allianz Research, the US and China are expected to account for around 62% of new global capacity additions through 2030, but the next wave of investment is becoming increasingly global. In Europe, Germany, the UK and Ireland remain major markets, but faster expansion is expected in Spain, Finland and Denmark, where power availability and permitting conditions can be more favorable. Across Asia Pacific, excluding China, installed capacity is projected to increase from around 9GW today to more than 28GW by 2030, with Malaysia expected to grow more than tenfold.
“AI is turning the latest generation of data centers from a specialist real estate asset into mission-critical infrastructure,” says Thomas Lillelund, CEO of Allianz Commercial. “The scale of investment is extraordinary and, as these centers evolve beyond traditional data storage to high-performance compute demands, success will increasingly depend on resilience: access to power, reliable supply chains, robust construction controls, as well as climate-aware site selection and insurance programs that reflect the true accumulation risk. Indeed, comprehensive insurance cover has become a prerequisite for financing many large-scale AI infrastructure projects.”

Resilience must be central to data center operations
The sector’s biggest constraints are increasingly physical rather than financial. Competitive advantage is increasingly determined by access to electricity, grid connections, permitting, specialized equipment and skilled labor. In the US alone, the construction industry faces a shortage of around 439,000 skilled workers, while an estimated 349,000 additional workers may be needed in 2026. Climate resilience is increasingly a strategic consideration rather than an operational afterthought. Around 79% of global data center capacity is already located in areas exposed to heightened natural catastrophe risk, while 54% is exposed to chronic heat and drought stress. Some of the fastest-growing AI infrastructure markets are also among the most climate-exposed, including Northern Virginia, US, Johor in Malaysia, and Marseille, France. Acute flood, wildfire and wind exposure is highest in the Americas, affecting 86% of capacity, while chronic heat and drought stress is greatest in Asia Pacific, where 89% of capacity is exposed.

Global data center insurance market will more than double by 2030
Insurance is evolving alongside the sector. As data centers assume a more critical role in infrastructure, comprehensive insurance cover has become a prerequisite for financing many large-scale AI infrastructure projects. Construction costs for a single AI campus can exceed US$20bn, with insured values rising substantially once high-performance computing equipment is installed. The global data center insurance market is projected to grow from around US$11bn today to more than US$24bn by 2030, reflecting rapid capacity expansion, rising insured values and increasing operational complexity. Demand is expected to extend beyond traditional property cover towards integrated solutions spanning construction, engineering, property, business interruption, cyber and liability, while also creating new opportunities in areas such as energy resilience, operational continuity, and technology risk.

Risk and claims trends: fire drives severity; water damage frequency
Allianz Commercial analysis of insurance industry data center-related claims shows that fire is the leading driver of loss severity, accounting for well over 50% of around €700mn (US$800mn) worth of losses. Natural catastrophe activity ranks second, followed by willful acts, which include crime and cyber incidents, followed by power failure. Water damage is the most frequent cause of data center claims, followed by willful acts, fire, and equipment breakdown. Business interruption is the primary driver of claims severity by line of insurance, highlighting the significant financial impact of operational downtime.

The data center risk profile is changing as facilities become larger, more complex, and more increasingly interdependent. Hyperscale and colocation of campuses can bring together multiple tenants, construction works, servers, supporting utilities and on-site infrastructure in one physical or operational space. A single event can therefore trigger claims across property, construction, business interruption, liability, cyber, and financial lines. Real-life claims case studies show that in hyperscale facilities, damage to external cooling systems, hot works-related fire damage, and a delay in start-up caused by power disturbances have each resulted in losses in the US$50mn to US$100mn range.

“For insurers, the key question is not only the value of the building, but the concentration of value and dependency inside and around it. Power, cooling, batteries, fiber routes, testing and commissioning, and business continuity planning are all part of the same risk picture. Effective risk mitigation must begin early and continue throughout the data center lifecycle. Resilience must be designed in from the earliest planning stage,” explains Christian Kolbe, Global Head of Construction Claims at Allianz Commercial.

Clarity between policies essential to avoid ambiguity
Data center projects encompass different project phases with several stakeholders and interests involved, which can create complications. During the construction phase, stakeholders include the owner, developer, contractor, and subcontractors, whereas in the operational phase, the stakeholders include the owner-operator, and potentially multiple tenants or end users. For example, different policies could respond to a hot works-related fire resulting in damage to a data center nearing completion, and this would impact different stakeholders.

“Clarity is critical with an insurance claim,” says Charlotte Field, Regional Head of Short-tail Claims, Asia, at Allianz Commercial. “Clearly documented handovers are essential between your construction all-risk policy and operational policy. There must be no ambiguity about practical completion, in order to avoid disputes over which policy responds to a particular event and the extent of cover.”

Hashtag: #AllianzCommercial


The issuer is solely responsible for the content of this announcement.

About Allianz Commercial

Allianz Commercial is the center of expertise and global line of Allianz Group for insuring mid-sized businesses, large enterprises and specialist risks. Among our customers are the world’s largest consumer brands, financial institutions and industry players, the global aviation and shipping industry as well as family-owned and medium enterprises which are the backbone of the economy. We also cover unique risks such as offshore wind parks, infrastructure projects or film productions. Powered by the employees, , and network of the world’s #1 insurance brand, we work together to help our customers prepare for what’s ahead: They trust us in providing a wide range of traditional and risk transfer solutions, outstanding and services as well as seamless handling. Allianz Commercial brings together the large corporate insurance business of Allianz Global Corporate & Specialty (AGCS) and the commercial insurance business of national Allianz Property & Casualty entities serving mid-sized companies. We are present in over 200 countries and territories either through our own teams or the Allianz Group network and partners. In 2025, the integrated business of Allianz Commercial generated around €17.3 billion in gross premium globally.

US Senator Bernie Sanders has urged OpenAI, Anthropic and Meta to pause the development of advanced artificial intelligence, arguing that emerging evidence of autonomous behaviour and powerful biological capabilities shows existing safety protections may no longer be sufficient. The Vermont senator addressed his demand to OpenAI chief executive Sam Altman, Anthropic chief executive Dario Amodei and Meta chief executive Mark Zuckerberg. Sanders said the companies should honour […]

Nvidia is joining forces with six of the world’s biggest investment groups to mobilise more than $500 billion for artificial intelligence infrastructure, creating financing platforms designed to expand access to the computing capacity underpinning the global AI boom. The chipmaker has signed memorandums of understanding with Apollo, BlackRock, Blackstone, Brookfield, Goldman Sachs and KKR. The firms plan to establish independent platforms that will provide dedicated pools of […]

Mark Zuckerberg has laid out his most expansive case yet for putting powerful artificial intelligence into the hands of billions of people, arguing that widely available “personal superintelligence” can improve education, work, healthcare and creativity while preventing control of advanced AI from becoming concentrated among governments and a handful of companies. The Meta chief executive’s essay, titled “The Future is for Everyone”, runs to more than 6,400 […]

Greenlogue/AP A consortium led by EDF power solutions has reached financial close on Oman’s 120-megawatt Jaalan Bani Bu Ali Wind Independent Power Project, clearing a key hurdle for construction and commercial operation targeted for the third quarter of 2027. EDF power solutions is developing the project with Al Khadra Partners, part of the Hind Bahwan Group, and OQ Alternative Energy. The partners secured financing after signing a […]

Meta has released Muse Glimmer, a 30-billion-parameter open-weight artificial intelligence model designed to run agentic workloads on consumer hardware, while preparing an open-weight version of its flagship Muse Spark 1.2 model for release within weeks. The launch marks a renewed push by Meta to make downloadable AI models a central part of its strategy after its Muse family initially moved towards controlled access. Muse Glimmer, released on […]

VISHNU RAJA
RYO YAMADA
HITORI GOTOH
IKUYO KITA
Just in:
Travel Insurance Was Built for the Few Who Claim. Ancileo’s Felt Coverage™ is for Everyone Else // Padmini follows Padmaja for ‘ghar vapsi’ // Toward a Shared Future for Humanity: Rethinking Civilizational Exchange // Dubai Introduces SHARH, an AI-Powered Platform Helping Entrepreneurs Buy, Sell and Manage Businesses in the UAE // Dar Global unveils $700m Trump development in Qatar // Hackers exploit public notes to distribute NodeLinkRAT malware // Jaiedco and Golden Bridge Announce Strategic Collaboration for a New Dubai Islands Development // LittleLives, Little Lab and SEGi College Sign MOU to Explore Early Childhood Education Collaboration Across ASEAN // PicCollage extends photo editing platform to web browsers // Sabarimala booking discrepancies prompt sabotage angle probe // Coinbase targets 2027 launch amid state gambling lawsuits // Alibaba shares slip despite 53% cloud revenue growth // International Business Leaders Say Xi’s Speech Boosts Confidence in Asia-Pacific Cooperation // PayerMax and ShopeePay Strengthen Strategic Partnership to Advance Digital Payment Collaboration in Southeast Asia // Crypto market loses $150 billion amid broad sell-off // Sui activates Hashi Bitcoin lending across partner network // ED searches five districts in probe against hawala // Promoting Common Human Development Through Exchanges and Mutual Learning Among Civilizations // Workday targets Honeydew purchase to unify AI metrics // Balagopal challenges CM over tax revenue //